United States · Bill · HR
H.R. 4449 (118th)
Pharmaceutical Security Production Act
Introduced
30 June 2023
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
14 August 2024
Summary
Pharmaceutical Security Production Act This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain. The commission must assess the security and vulnerabilities of the domestic pharmaceutical supply chain in the United States and recommend improvements, including by developing metrics for domestic manufacturing programs, proposing solutions to strengthen the domestic manufacturing workforce, and evaluating ways to support a financial market for domestically manufactured products. The commission terminates four years after the bill is enacted.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 30 June 2023
Introduced in House (PDF)
Introduced in House · EN · 30 June 2023
Introduced in House
summary · EN · 30 June 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/4449
- Open data entity: https://api.congress.gov/v3/bill/118/hr/4449